These data suggest that equivalent TNF exposure has different effects in breast cancer: ubiquitin architecture, caspase-8/cFLIP balance, kinase competency for RIPK1 necroptosis, ligand form, and receptor microdomain residency combine to favor survival, apoptosis, or necroptosis. This evidence concerns the gene RIPK1 and breast carcinoma.